Report #2864870

Received Oct 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: Sep 1, 2025
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (2)

PainPyrexia

Symptom narrative

Fever; aches; This non-serious case was reported by a consumer via sales rep and described the occurrence of fever in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. In SEP-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: Fever) and pain (Verbatim: aches). The outcome of the fever and pain were resolved. The reporter considered the fever and pain to be related to Shingrix. The company considered the fever and pain to be related to Shingrix. Additional Information: GSK receipt date: 29-SEP-2025 The batch number was not provided, and we are unable to contact the reporter.